Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Medpace Holdings, Inc. before investing.

In this article, we go over a few key elements for understanding Medpace Holdings, Inc.’s stock price such as:

• Medpace Holdings, Inc.’s current stock price and volume
• Why Medpace Holdings, Inc.’s stock price changed recently
• Upgrades and downgrades for MEDP from analysts
• MEDP’s stock price momentum as measured by its relative strength

About Medpace Holdings, Inc. (MEDP)

Before we jump into Medpace Holdings, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Want to learn more about Medpace Holdings, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Medpace Holdings, Inc..

Medpace Holdings, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Medpace Holdings, Inc.’s stock price was $577.110.

Medpace Holdings, Inc. is down 0.21% from its previous closing price of $578.300.

During the last market session, Medpace Holdings, Inc.’s stock traded between $565.740 and $579.570. Currently, there are approximately 28.17 million shares outstanding for Medpace Holdings, Inc..

Medpace Holdings, Inc.’s price-earnings (P/E) ratio is currently at 33.8, which is low compared to the Life Sciences Tools & Services industry median of 43.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Medpace Holdings, Inc. Stock Price History

Medpace Holdings, Inc.’s (MEDP) price is currently up 8.97% so far this month.

During the month of July, Medpace Holdings, Inc.’s stock price has reached a high of $677.900 and a low of $514.470.

Over the last year, Medpace Holdings, Inc. has hit prices as high as $677.900 and as low as $373.000. Year to date, Medpace Holdings, Inc.’s stock is up 2.75%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Medpace Holdings, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Medpace Holdings, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Medpace Holdings, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Medpace Holdings, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Medpace Holdings, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Medpace Holdings, Inc. (MEDP) by visiting AAII Stock Evaluator.

Relative Price Strength of Medpace Holdings, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Medpace Holdings, Inc. has a weighted four-quarter relative price strength of 12.07%, which translates to a Momentum Score of 85 and is considered to be Very Strong.

Want to learn more about how Medpace Holdings, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Medpace Holdings, Inc. Stock Price: Bottom Line

As of July 31, 2026, Medpace Holdings, Inc.’s stock price is $577.110, which is down 0.21% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Medpace Holdings, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.